COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment (opens original article in a new tab)

COSCIENS Biopharma Inc. is implementing a share capital amendment through a consolidation and split, affecting shareholder holdings and trading on the Toronto Stock Exchange.

• COSCIENS Biopharma Inc. announced a share capital amendment involving a consolidation and split of common shares.
• Shareholders with fewer than 150 common shares will receive cash consideration, while others will get additional shares.
• The amendment is effective July 3, 2026, with shares trading under the same symbol post-amendment.